The central pathology of APOEε4 involves a vicious cycle of lipid metabolism disorders and neuroinflammation. Consequently, upregulating lipidation transporters, such as ABCA1, to improve APOEε4's ...
Revolutions in gene therapy are rapidly changing the landscape of modern medicine. Revolutions in gene therapy are rapidly changing the landscape of modern medicine, forcing society and science alike ...
Shares of the gene therapy developer rose 12.5% to $9.55 in premarket trading on Monday after the news. Sign up here. Under the deal, MeiraGTx will get an upfront payment of $75 million and ...
An experimental MeiraGTx gene therapy that has clinical data showing reversal of blindness in children born with a rare, inherited eye disorder is heading to Eli Lilly. According to the terms of the ...
HYOGO, Japan--(BUSINESS WIRE)--JCR Pharmaceuticals Co., Ltd. (TSE 4552; “JCR”), a global specialty biopharmaceutical company dedicated to developing therapies for rare and genetic diseases, today ...
The MarketWatch News Department was not involved in the creation of this content. -- Ready-to-use solution for Amperia benchtop platform supports rapid, reliable quantification across a range of ...
The expanded kit range enhances the utility of Amperia for scientists working across gene therapy development and process workflows, offering a practical, dependable approach to total capsid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback